Evidence map›Paper›PMID 37953022›Full record

ReviewHeart failure clinics2024

Interatrial Shunt Devices.

Husam M Salah, Claudia Baratto, Dmitry M Yaranov, Karl-Philipp Rommel, Satyanarayana Achanta, Sergio Caravita, Vinay Kumar Reddy Vasanthu, Marat Fudim

Open access · greenAbstract readReview
In one paragraph

Review in Heart failure clinics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. ANMCO position paper: diagnosis and treatment of heart failure with preserved systolic function.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 3 countries.

Husam M SalahDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Claudia BarattoDivision of Cardiology, Dyspnea and Pulmonary Hypertension Clinic, Ospedale San Luca IRCCS Istituto Auxologico Italiano, Milano, Italy.
Dmitry M YaranovBaptist Heart Institute, Baptist Memorial Hospital, Memphis, TN, USA.
Karl-Philipp RommelDeptartment of Cardiology, Heart Center at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany; Cardiovacular Research Foundation, New York, NY, USA.
Satyanarayana AchantaDepartment of Anesthesiology, Duke University School of Medicine, Durham, NC, USA.
Sergio CaravitaDivision of Cardiology, Dyspnea and Pulmonary Hypertension Clinic, Ospedale San Luca IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Management, Information and Production Engineering, University of Bergamo, Dalmine, Province of Bergamo, Italy.
Vinay Kumar Reddy VasanthuDepartment of Anesthesiology, Duke University School of Medicine, Durham, NC, USA.
Marat FudimDivision of Cardiology, Department of Medicine, Duke University, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA. Electronic address: marat.fudim@gmail.com.
Duke University · USBaptist Memorial Hospital · USClinical Research Institute · USIRCCS Istituto Auxologico Italiano · ITLeipzig Heart Institute · DEUniversity of Arkansas for Medical Sciences · USUniversity of Bergamo · IT

Funding

Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation InjuryU01ES030672 · NIEHS · DUKE UNIVERSITY · PI ACHANTA, SATYANARAYANA, JORDT, SVEN-ERIC · 2019 to 2021
$2.3M
Pulmonary cell fate and lung repair in rodent and porcine models of chlorine and phosgene inhalation injuriesR01ES034387 · NIEHS · DUKE UNIVERSITY · PI ACHANTA, SATYANARAYANA, JORDT, SVEN-ERIC · 2022 to 2024
$1.4M
Specialized pro-resolving mediators as potential medical countermeasures in a pig model of chlorine gas-induced acute lung injuryR21ES030331 · NIEHS · DUKE UNIVERSITY · PI ACHANTA, SATYANARAYANA, JORDT, SVEN-ERIC · 2020 to 2021
$443k
Inhibition of soluble epoxide hydrolase protects against phosgene-induced lung injuriesR21ES033020 · NIEHS · DUKE UNIVERSITY · PI ACHANTA, SATYANARAYANA · 2021 to 2022
$443k
NIEHS NIH HHS R01 ES034387NIEHS NIH HHS R21 ES030331NIEHS NIH HHS R21 ES033020NIEHS NIH HHS U01 ES030672
6 · The paper itself

Abstract

Elevated left atrial pressure during exercise is a hallmark of heart failure (HF) and is associated with adverse left atrial remodeling and poor outcomes. To decompress the pressure-overloaded left atrium in patients with HF, several device-based approaches have been developed to create a permanent, pressure-dependent, left-to-right interatrial shunt. Such approaches are currently in various stages of investigations in both HF with reduced ejection fraction (EF) and HF with preserved EF. This review discusses the evolution of the concept of left atrial decompression and summarizes the current landscape of device-based approaches used for left atrial decompression.

Indexed as

Atrial FibrillationHeart FailureAtrial PressureCardiac CatheterizationHeart AtriaHumansStroke VolumeDevice therapyHeart failureHFpEFHFrEFInteratrial shuntLeft atrial pressure

Identifiers

PMID37953022
PMCPMC11232059
OpenAlexW4383106607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.